323 related articles for article (PubMed ID: 16956916)
21. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.
Siu CW; Jim MH; Zhang X; Chan YH; Pong V; Kwok J; Kung AW; Lau CP; Tse HF
Am J Cardiol; 2009 Feb; 103(4):540-3. PubMed ID: 19195517
[TBL] [Abstract][Full Text] [Related]
22. Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study.
Nergårdh AK; Rosenqvist M; Nordlander R; Frick M
Eur Heart J; 2007 Jun; 28(11):1351-7. PubMed ID: 17329409
[TBL] [Abstract][Full Text] [Related]
23. Clustering of RR intervals predicts effective electrical cardioversion for atrial fibrillation.
Van Den Berg MP; Van Noord T; Brouwer J; Haaksma J; Van Veldhuisen DJ; Crijns HJ; Van Gelder IC
J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1027-33. PubMed ID: 15363075
[TBL] [Abstract][Full Text] [Related]
24. Study of ECG-derived atrial fibrillatory rate for prediction of the outcome of cardioversion of short duration atrial fibrillation (CASAF).
Holmqvist F; Seifert MB; Fagerström VL; Nault I; Östenson S; Carlson J; Ekelund U; Platonov PG
J Electrocardiol; 2023; 81():20-22. PubMed ID: 37480800
[TBL] [Abstract][Full Text] [Related]
25. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
Wozakowska-Kapłon B; Opolski G; Janion M
Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
[TBL] [Abstract][Full Text] [Related]
26. Signal-averaged P wave reflects change in atrial electrophysiological substrate afforded by verapamil following cardioversion from atrial fibrillation.
Redfearn DP; Skanes AC; Lane J; Stafford PJ
Pacing Clin Electrophysiol; 2006 Oct; 29(10):1089-95. PubMed ID: 17038141
[TBL] [Abstract][Full Text] [Related]
27. Fibrillatory rate response to candesartan in persistent atrial fibrillation.
Bollmann A; Tveit A; Husser D; Stridh M; Sörnmo L; Smith P; Olsson SB
Europace; 2008 Oct; 10(10):1138-44. PubMed ID: 18664477
[TBL] [Abstract][Full Text] [Related]
28. Exercise testing for non-invasive assessment of atrial electrophysiological properties in patients with persistent atrial fibrillation.
Husser O; Husser D; Stridh M; Sörnmo L; Corino VD; Mainardi LT; Lombardi F; Klein HU; Olsson SB; Bollmann A
Europace; 2007 Aug; 9(8):627-32. PubMed ID: 17595231
[TBL] [Abstract][Full Text] [Related]
29. Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion.
Oral H; Ozaydin M; Sticherling C; Tada H; Scharf C; Chugh A; Lai SW; Pelosi F; Knight BP; Strickberger SA; Morady F
J Cardiovasc Electrophysiol; 2003 Feb; 14(2):182-5. PubMed ID: 12693502
[TBL] [Abstract][Full Text] [Related]
30. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
Larsen MT; Lyngborg K; Pedersen F; Corell P
Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
[TBL] [Abstract][Full Text] [Related]
31. Time and frequency recurrence analysis of persistent atrial fibrillation after electrical cardioversion.
Alcaraz R; Rieta JJ
Physiol Meas; 2009 May; 30(5):479-89. PubMed ID: 19369714
[TBL] [Abstract][Full Text] [Related]
32. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
[TBL] [Abstract][Full Text] [Related]
33. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of biphasic shock for transthoracic cardioversion of persistent atrial fibrillation: can we predict energy requirements?
Wozakowska-Kaplon B; Janion M; Sielski J; Radomska E; Bakowski D; Bartkowiak R
Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):764-8. PubMed ID: 15189531
[TBL] [Abstract][Full Text] [Related]
35. Impact of matrix metalloproteinase-2 levels on long-term outcome following pharmacological or electrical cardioversion in patients with atrial fibrillation.
Kato K; Fujimaki T; Yoshida T; Oguri M; Yajima K; Hibino T; Murohara T
Europace; 2009 Mar; 11(3):332-7. PubMed ID: 19147485
[TBL] [Abstract][Full Text] [Related]
36. Electrocardiographic evidence of ventricular repolarization remodelling during atrial fibrillation.
Tan HL; Smits JP; Loef A; Tanck MW; Hardziyenka M; Campian ME
Europace; 2008 Jan; 10(1):99-104. PubMed ID: 18094018
[TBL] [Abstract][Full Text] [Related]
37. Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation.
Kosior DA; Stawicki S; Wozakowska-Kapłon B; Szulc M; Opolski G; Rabczenko D
Kardiol Pol; 2005 Jul; 63(7):36-47; discussion 48-9. PubMed ID: 16136427
[TBL] [Abstract][Full Text] [Related]
38. Amiodarone after unsuccessful direct-current cardioversion of persistent atrial fibrillation.
Kosior DA; Wozakowska-Kapłon B; Jasik M; Kiliszek M; Rabczenko D; Opolski G
Kardiol Pol; 2005 Dec; 63(6):585-92; discussion 593-4. PubMed ID: 16380855
[TBL] [Abstract][Full Text] [Related]
39. Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation.
Soran H; Younis N; Currie P; Silas J; Jones IR; Gill G
QJM; 2008 Mar; 101(3):181-7. PubMed ID: 18202088
[TBL] [Abstract][Full Text] [Related]
40. Relation of early termination of persistent atrial fibrillation by cardioversion or drugs to ablation outcomes.
Winkle RA; Mead RH; Engel G; Patrawala RA
Am J Cardiol; 2011 Aug; 108(3):374-9. PubMed ID: 21600534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
